key: cord-0922752-e3woty0f authors: Chowdhury, Debashish; Krishnan, Anand; Duggal, Ashish; Datta, Debabrata; Mundra, Ankit; Deorari, Vaibhav; Tomar, Apoorva; Koul, Arun title: An Internet‐based study on the impact of COVID‐19 pandemic‐related lockdown on migraine in India date: 2021-08-30 journal: Acta Neurol Scand DOI: 10.1111/ane.13525 sha: 11ba0f79c55e69390eb7f5330a538c3489821f60 doc_id: 922752 cord_uid: e3woty0f OBJECTIVES: To assess the impact of lockdown during the COVID‐19 pandemic on migraine patients in India on disease activity, healthcare accessibility, and quality of life (QoL). MATERIALS & METHODS: This internet‐based survey study using a structured questionnaire was conducted from 27th April to 31st July 2020. Previous physician‐diagnosed migraine patients or those fulfilling any two of three clinical features (limitation of activities for >1 day, associated nausea or vomiting, and photophobia or phonophobia) were diagnosed as migraine patients. QoL was captured using a Likert scale and determinants of poor QoL were identified by logistic regression. RESULTS: A total of 4078 persons completed the full survey out of which 984 (24.1%) had migraine (mean age 35.3 ±11.2). Compared to pre‐lockdown, 51.3% of migraineurs reported worsening of their headaches in terms of increased attack frequency (95.6%), increased headache days (95%), increased attack duration (89.9%) and increased headache severity (88.1%). The worsening was attributed to anxiety due to the pandemic (79.7%), inability or difficulty to access healthcare (48.4%) and migraine medicines (48.9%), and financial worries (60.9%). 26.8% of migraineurs reported poor QoL compared to 7.37% of non‐migraineurs [p<0.0001]. Migraine affected QoL in 61.4% of migraineurs. The predictors of poor QoL on logistic regression included worsening migraine during the lockdown (AOR 4.150; CI 2.704‐ 6.369) and difficulty accessing migraine medicines (AOR 4.549; CI 3.041‐ 6.805). Employment as an essential COVID‐19 worker (AOR 0.623; CI 0.409‐ 0.950) protected against poor QoL. CONCLUSIONS: COVID‐19 pandemic‐related lockdown greatly impacted migraine patients in India which significantly reduced their QoL. culty in accessing health care and medications, and financial worries as a result of economic slowdown. 4 Contrarily, amelioration of some of the stressors like everyday travel to work, spending more time with family, and flexibility of planning and scheduling the work from home (especially for persons living in cities) might have contributed to decreasing migraine attacks. 5, 6 It has been estimated that approximately 14.7% of the world's population suffer from migraine. 7 In India, however, a recent epidemiological study has shown a higher 1-year prevalence of 25%. 8 The impact of the COVID-19 pandemic and subsequent lockdown on patients with migraine has been documented in various parts of the world. [4] [5] [6] [9] [10] [11] Various countries in the world have tried to cope up with this situation by providing health care using telemedicine which has been strongly advocated. 12, 13 The impact of the lockdown and the coping strategies adopted by the migraineurs in India is not known. We, therefore, aimed to assess the impact of lockdown on Indian migraine patients during the COVID-19 pandemic in terms of change in the disease activity, accessibility to health care, and whether migraine affected their quality of life (QoL) through an Internet-based survey, as the physical survey was not possible due to lockdown as well as pandemic fears. We recruited participants aged 18 years and above from April 27, 2020 to July 31, 2020 using a specifically designed questionnaire The questionnaire was divided into five sections (Appendix S1). The demographic section asked questions on age, gender, occupation, marital status, habitation, the region in India, and status as an essential care worker for COVID-19 (doctor/nurse/paramedic/ press/police/defense). Section 2 was for screening for migraine and a diagnosis of migraine was made if the participants confirmed that they suffer from recurrent headaches and additionally fulfilled either of the following criteria: (a) those who reported that they have already been diagnosed as suffering from migraine by a physician previously; (b) Those with recurrent headache who had any two of these limitation of activities for a day or more, nausea or vomiting during the headache, and photophobia or phonophobia. 14 Rest of the participants who did not complain of recurrent headaches or fulfill the criteria for diagnosis of migraine were considered as participants without migraine and were asked only one more question regarding their QOL during the past month. Section 3 comprised of questions on characteristics of migraine-like migraine days/month, duration, severity, and use of acute and prophylactic medications for migraine before the COVID-19 pandemic and lockdown. In the fourth section, the participants were asked about the impact of the COVID-19 pandemic and lockdown on their migraine headaches in terms of the above parameters of disease activity and the reasons for the changes if any. In the fifth section, the participants were asked questions regarding the impact of the COVID-19 pandemic and lockdown on their ability to access health care and medications, the reasons for difficulty for such access if any; management of headache episode during the lockdown; their QoL during this period and if their headaches affected their QoL. Participants without migraine were asked only one more question after section 2 regarding their QoL during the past month. QoL was captured using a Likert scale (very good/good/average/bad/very bad). The primary outcome measure was the impact of COVID-19 pandemic and lockdown on qualitative changes in attack frequency, headache days/last month, headache attack duration, and severity. Secondary outcome measure included QoL during the past 1 month that was compared between participants with and without migraine. Demographic characteristics were summarized using descriptive statistics. Categorical data were summarized as frequencies and percentages. Continuous data were summarized as means. Post hoc, the 5 response Likert scale for QoL was converted into two categories namely "good" (which included very good/good/average responses) and "poor" (which included bad/very bad responses) for comparison. The categorical variables were compared using the chi-square test (with Yates correction) and OR, upper and lower CI, and p values were estimated. Continuous variables were compared using an independent sample Student t-test. For assessing the determinants of QoL, initially, univariate analysis was done by comparing the independent variables with QoL as the dependent variable. All statistically significant variables were then entered into the multivariate logistic regression model to explore the factors that were independently associated with poor QoL. The level of significance was set at p < .05. Data were analyzed using SPSS statistical software version 21. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. Only the parameters detailing the impact of lockdown on migraine headaches, accessibility to health care, and quality of life are analyzed in this paper. The rest of the data will be presented in a separate paper later. Among the migraineurs, 347 were males (35.30%) as compared to 68.8% males among 3094 participants without migraine. The mean age of the participants with and without migraine was 35.32 ± 11.16 and 32.51 ± 11.44 years, respectively. Overall, the study participants represented a wide range of occupations, regions of the country (though predominantly from North India) with a dominance of people residing in a metropolitan city. The demographic details of the participants have been depicted in Table 1 . (Table 2) . Among the migraineurs, only 278 (28.25%) had access to a doctor for their headache during the lockdown through personal visits (40.6%), telephone/mobile (53.6%), chatbox (10.8%), SMS (9.3%), videoconferencing (6.8%), and via email (2.9%). Most of them (86%) were however satisfied with remote consultation. The reasons cited by participants for not being able to access their doctors were inability to contact the doctor (5.9%), closure of clinic (4.5%), the doctor not providing a consultation without a personal visit (1.3%), lack of transport (50.3%), and fear of contracting the disease in a doctor's clinic (38%). On the issue of access to medications for migraine (both preventive and acute relief) during the lockdown, 505 (51.3%) participants stated that there was no interruption in the access at any point of time, 416 (42.28%) could access with some difficulty. 63 (6.4%) participants did not have access to medications forcing them to use other alternatives remedies-60.3% took rest and slept during their headaches, 31.3% used balm/oil, and 36.5% used other household remedies. During the lockdown period, 446 (47.36%) participants had at least one episode of severe headache that did not resolve with usual medications and lasted for days (Table 3) . The determinants of poor QoL by univariate analysis were female sex, married status, those who were employed, and those with a monthly headache frequency of ≥15 days (pre-lockdown), those who were using a preventive medication, those who reported worsening of their migraine, and those who had difficulty or did not have access to doctors and medications during the lockdown. Those employed in essential COVID-19 duties had good QoL ( Table 4) (Table 4 ). This Internet-based survey study found that the COVID-19 pandemic-related lockdown negatively impacted Indian migraine patients. Indian migraineurs had worsening of their migraine in terms of frequency, headache days, severity, and duration. A comparison of the QoL during the previous month before the survey showed significant differences between those with migraine and those without. Also, 61% of the migraineurs reported that their headaches had an impact on their QoL. Our prevalence of migraine (24%) among the participants matches well with that found in a population-based study conducted in Karnataka (25.2%). 8 The majority of the migraineurs (83%) who participated in the survey were previously diagnosed by physicians. The mean age of migraineurs was 35.32 ± 11.16 years and the female to male ratio was 1.83. The baseline pre-lockdown headache characteristics showed a high disease burden in terms of migraine frequency (median 5 days per month) and headache severity (moderate to severe in 93.8%). These estimates are consistent with Karnataka study from South India that reported the prevalence of migraine was highest between 26 and 45 years of age, the female to male ratio was 1.82, 38% of migraineurs had >3 days of migraine per month and 96.7% had "quite bad" or "very bad" headache intensity. 15 These results, therefore, indicate that the survey, though suffering from biases inherent in an Internet-based survey has provided valid estimates. During the lockdown, migraine reportedly worsened in 51% of the participants while 11% were unsure. Similar to our study, another web-based study by Al-Hashel et al. 4 showed that in comparison with the pre-pandemic period, 59.6% of migraineurs reported an increase in migraine frequency, and 64.1% reported an increase in severity. Contrarily, few studies from Netherlands and Italy have shown opposite results. One e-diary-based study from a tertiary headache care center found significant improvement of headache in terms of attack frequency, acute medication use, and overall wellbeing for an initial 2 months after the lockdown as compared to the pre-lockdown period. 5 The authors attributed this improvement to combining effects of several factors like fewer work-related stresses, ability to take rest during headache attack, work from home, and luxury to choose how to organize one's time. These results might not be comparable to the migraine patients from the general population. Similarly, another web-based study in pediatric and adolescent patients also found significant improvement of migraine which was attributed to decrease school, sports, and examination-related stresses. 11 This study however found a mild increase of headache in those patients who developed increased anxiety during the lockdown. Another interview-based study of migraine patients included in the Italian headache registry also found mild improvement in headache frequency, intensity, and acute medication use. 6 Two more studies from Italy have also shown similar results. 9,10 However, a recent study in an Italian cohort showed that prolongation of the pandemic worsened migraine evolution during the second wave of the pandemic. 16 It is important to note that our survey population in India are limited. 23 to make migraine worse. 28, 29 Additionally, the COVID-19 pandemic itself has been shown to cause deterioration of mental health globally in people suffering from chronic conditions. 30 In particular, increased stress, anxiety, and depression have been documented during COVID-19 by many studies including a metanalysis. [31] [32] [33] [34] Indian studies have also reported some major mental health issues like stress, anxiety, depression, insomnia, denial, anger, and fear. 35 A significant number of participants (29%) with migraine were working as essential COVID-19 workers during this time. This may be because migraine is more common among health care professionals (than in the general population) 40 who constituted the bulk of the essential COVID-19 workforce. It is possible that the essential COVID-19 workers although stressed had better access to health care and therefore were able to tackle their migraines better. They were also more likely to be aware of the COVID-19 appropriate behaviors and were motivated and dedicated to their work as a group. In a recent study, it was found that although individual factors, notably, anxiety over the disease and personal identity did impact QoL, group-based or social identification of individuals also impacted their QoL. In fact, the study found that the effect of group identities (family, religious group, and nation) is above that of personal or individual factors in predicting QoL. 41 During the COVID-19 pandemic and lockdown, social and moral responsibilities were a major empowering force for the essential care workers and one study from India actually documented that although initial stress levels were very high among the workers, positive cognitive reappraisal with adaptive strategies helped the team to collectively cope with the situation effectively. 42 There are a few limitations of our study. As is true for any major urban metropolitan cities (67%) also indicate a selection bias. We did not capture how many migraineurs actually contracted COVID-19 before they undertook the survey which might have a bearing on their migraine burden and QoL. Although we identified stress as an important contributor to the worsening of migraine, we did not measure it. Finally, we did not estimate the magnitude of medication overuse as a potential cause of migraine worsening during this period. Despite these few limitations, we believe that our survey clearly showed that the COVID-19 pandemic and lockdown affected Indian migraine patients adversely with resultant poor QoL. We, therefore, suggest that telemedicine be encouraged for wider accessibility to doctors and medications. The professional bodies, organizations of doctors, health authorities, and advocacy groups should advise the government for reframing laws, regulations, coding, and reimbursement options for teleconsultation and online access to headache medicines. Migraine patients should be taught about neurobehavioral approaches including yoga and meditation which can be practiced at home to decrease stress and thereby improve headaches. Such an approach has yielded positive results in European studies during the lockdown. 43 The essential COVID-19 workers with migraine need to be identified and provided with a simplified advisory regarding how to manage and lessen their migraine burden during pandemic times. 12 A combined and holistic approach shall be useful. None. No conflict of interest. The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions. https://orcid.org/0000-0002-0293-5438 The impact of novel coronavirus COVID-19 on noncommunicable disease patients and health systems: a review Continuum of care for non-communicable diseases during COVID-19 pandemic in rural India: a mixed methods study Impact of coronavirus disease 2019 (COVID-19) pandemic on patients with migraine: a web-based survey study Effect of lockdown during COVID-19 on migraine: a longitudinal cohort study Investigating the effects of COVID-19 quarantine in migraine: an observational cross-sectional study from the Italian National Headache Registry (RICe) Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, of Disease Study Headache disorders and public ill-health in India: prevalence estimates in Karnataka State Locking down the CGRP pathway during the COVID-19 pandemic lockdown: the PandeMig study Impact of quarantine due to COVID infection on migraine: a survey in Genova Migraine symptoms improvement during the COVID-19 lockdown in a cohort of children and adolescents Managing migraine in the times of COVID-19 pandemic Hospital-based headache care during the Covid-19 pandemic in Denmark and Norway A self-administered screener for migraine in primary care: the ID migraine validation study The burden attributable to headache disorders in India: estimates from a community-based study in Karnataka State Migraine during COVID-19: data from second wave pandemic in an Italian Cohort Is provision of healthcare sufficient to ensure better access? An exploration of the scope for public-private partnership in India Preliminary results: rapid assessment of service delivery for noncommunicable diseases during the COVID-19 pandemic A randomized trial of telemedicine efficacy and safety for non acute headaches Telemedicine in the management of non-acute headaches: a prospective, openlabelled non-inferiority, randomized clinical trial Telemedicine in neurology: telemedicine Work Group of the American Academy of Neurology update Telemedicine in India: a tool for transforming health care in the era of COVID-19 pandemic Media exposure to COVID-19 predicted acute stress: a moderated mediation model of intolerance of uncertainty and perceived social support COVID-19 stress and depression: examining social media, traditional media, and interpersonal communication The stress and migraine interaction Stress, anxiety, depression and migraine Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals Psychological impact and associated factors during the initial stage of the coronavirus (COVID-19) pandemic among the general population in Spain A nationwide survey of psychological distress among Italian people during the COVID-19 pandemic: immediate psychological responses and associated factors Generalized anxiety disorder, depressive symptoms and sleep quality during COVID-19 outbreak in China: a webbased cross-sectional survey Prevalence of stress, anxiety, depression among the general population during the COVID-19 pandemic: a systematic review and meta-analysis Depression, anxiety and stress among indians in times of Covid-19 lockdown Mental health implications of COVID-19 pandemic and its response in India Health, psychosocial, and economic impacts of the COVID-19 pandemic on people with chronic conditions in India: a mixed methods study Assessment of migraine disability using the migraine disability assessment (MIDAS) questionnaire: a comparison of chronic migraine with episodic migraine Quality of life in chronic daily headache-astudy in a general population Higher migraine risk in healthcare professionals than in general population: a nationwide population-based cohort study in Taiwan Quality of life in the COVID-19 pandemic in India: exploring the role of individual and group variables Challenges, experience and coping of health professionals in delivering healthcare in an urban slum in India during the first 40 days of COVID-19 crisis: a mixed method study Lessons from lockdown -behavioural interventions in migraine Additional supporting information may be found online in the Supporting Information section.